CV

Covista Inc.

CVSAConsumer DefensiveNASDAQ

Education & Training Services

PriceMA150MA200
Loading chart…
End-of-day data · ScananceOpen live chart on TradingView ↗
Indicator snapshot · Today
Premium
Today's indicator reading is locked

Free plan shows historical signals only. Upgrade to see this ticker's current MA150, MA200, RSI, and MACD readings.

Upgrade to see today →
Financials · Annual
Revenue
$1.95B
+9.3% YoY
Net Income
$251.6M
+6.1% YoY
EBITDA
$467.3M
+9.4% YoY
Free Cash Flow
$323.9M

Scan Results

Daily timeframe
1 recent day hidden. Fresh signals are a Premium featureUpgrade →
DateIndicatorDetails
Sep 3 MACD Negative CrossoverHistogram -0.1369, negative momentum
Sep 2 MACD Negative CrossoverHistogram -0.0397, negative momentum
About Covista Inc.

Covista Inc., together with its subsidiaries, provides healthcare education in the United States, Barbados, St. At a $4.36B market cap, Covista Inc. ranks as a mid-cap company within consumer defensive.

Where CVSA stands vs its 150-day and 200-day moving averages

As of the September 3, 2026 close, CVSA finished 13.78% above its 150-day moving average ($117.91) and 17.40% above its 200-day moving average ($114.28). This snapshot is end-of-day data shown with a five-trading-day delay on the free plan; Premium members see readings from the latest close.

Is CVSA overbought or oversold?

At the September 3, 2026 close, CVSA's RSI(14) was 54.0, in neutral territory (between 30 and 70). The MACD histogram was negative, so short-term momentum leaned bearish at that close. These readings are historical, refresh daily after market close, and are not investment advice.

Key stats
Market Cap$4.36B
P/E (TTM)17.10
Fwd P/E12.80
EPS$7.49
Beta0.63
52W Change-5.9%
ROE18.6%
Analysis

On the balance sheet, CVSA has $406.3M in cash with $905.5M in obligations. The ability to service this debt comfortably depends on continued operational cash generation. Annual free cash flow of $323.9M supports ongoing capital allocation decisions and provides a cushion against unexpected expenses or downturns. Return on equity stands at 18.6%, which is strong for the sector. ROE measures how effectively a company uses shareholder capital to generate profits. An ROA of 8.5% suggests reasonable efficiency in deploying the company's asset base. Revenue has grown from $1.45B (2023) to $1.95B (2026), reflecting a 35% increase over the period.

With a beta below 0.7, Covista Inc. typically sees smaller price swings than the overall market, offering a degree of stability during turbulent periods. No single metric tells the full story. Reviewing CVSA's risk profile alongside its fundamentals and technical indicators provides a more complete picture.

Links
More Consumer Defensive stocks
Browse all stocks →
Not financial advice. Scanance shows end-of-day technical indicators (not real-time prices) for information only. Results can be wrong; past performance does not guarantee future results.PrivacyTerms